Manufacturing B BioProcess International
Responsible outsourcing: Avoiding common pitfalls in biopharma partnerships
An executive from 53Biologics emphasizes the importance of strategy and risk mitigation, especially for small life science firms.
Manufacturing headlines from across biotech and life sciences, gathered from the industry press and linked straight to the publisher. Every story links straight to its publisher.
Manufacturing B BioProcess International
An executive from 53Biologics emphasizes the importance of strategy and risk mitigation, especially for small life science firms.
Manufacturing
GEN
In this GEN webinar, Chris Nieder, an expert in viral vector programs, will examine how strategically designed preclinical manufacturing campaigns provide a practical foundation for GMP production. The post How Preclinical Manufacturing Can De-Risk the Path to GMP-Ready Viral Vec…
Manufacturing B BioProcess International
The facility strengthens the firm's advanced therapy supply chain, complementing its manufacturing plants in the US.
Manufacturing P Pharmaceutical Commerce
At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.
Manufacturing P Pharmaceutical Executive
Pharma logistics are overqualified by design — and how agentic AI can now optimize across thousands of lanes in days, not months.
Manufacturing
Pharmaceutical Technology
Executives from companies such as Leo Pharma and Daiichi Sankyo debated outsourcing selections and whether size is better in manufacturing.
Manufacturing B BioProcess International
The company’s aptly named Dalton engine claims it can discover and manage antibodies at scale.
Manufacturing B BioProcess International
As the firm continues to expand its global footprint, we spoke with an executive about what life science companies should consider when choosing research and manufacturing partners.
Manufacturing P Pharmaceutical Executive
Pharma AI adoption fails not because of the technology — but because organizations deploy tools before they're ready to use them.
Manufacturing P Pharmaceutical Commerce
Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.
Manufacturing B BioPharm International
Alvotech turns to a CDMO's 40,000-liter Syracuse facility for biosimilar drug substance as it expands its manufacturing network.
Manufacturing P Pharmaceutical Commerce
Adding artificial intelligence (AI) to legacy pharma supply chain systems requires auditable human intelligence to fix data and trust gaps.
Manufacturing P Pharmaceutical Executive
Adding artificial intelligence (AI) to legacy pharma supply chain systems requires auditable human intelligence to fix data and trust gaps.
Manufacturing
Pharmaceutical Technology
The biotech’s VP of Drug Product Operations Michelle Rodriguez on how it works with CDMOs.
Manufacturing
Pharmaceutical Technology
Rocket Pharmaceuticals has entered into a credit facility agreement of up to $150m with Hercules Capital to support the ongoing development of its cardiovascular portfolio.
Manufacturing P Pharmaceutical Executive
Pfizer and J&J supply chain experts on why health authorities now ask not just whether your quality systems work — but how fast you can adapt.
Manufacturing
European Biotechnology
Oxford-based Sensible Biotechnologies has secured a $47 million (€42 million) financing package to scale a platform that makes mRNA in living cells, targeting manufacturing costs and unwanted immune activation that can limit its use in treatments beyond vaccines. The post Sensibl…
Manufacturing
MedTech Dive
BD plans to increase U.S. production of essential medical consumables in exchange for relief from future tariffs on its products.
Manufacturing
GEN
Dillico’s GMP-ready Continuous Manufacturing by Engineering, Not Hype The post Inside All-ScaleFlow: Continuous End-to-End RNA-LNP Manufacturing appeared first on GEN - Genetic Engineering and Biotechnology News.
Manufacturing
Pharmaceutical Processing World
BD (Becton, Dickinson and Co.) (NYSE: BDX) has reached an agreement with the Trump administration to invest billions of dollars in U.S. operations in exchange for tariff relief. “This agreement reflects a shared commitment between the U.S. Government and BD to strengthening Ameri…
Manufacturing P Pharmaceutical Commerce
Swisslog's Mark Beers discusses how software helps pharma supply chains adapt to shifting portfolios, strengthen inventory verification and build trust.
Manufacturing P pharmaphorum
AstraZeneca cuts ribbon on new R&D facility in Massachusetts Phil.Taylor Tue, 06/10/2026 - 12:16
Manufacturing P Pharmafile
ESTEVE CDMO is investing a further $17.5m to expand capacity and containment capabilities at its Morton Grove facility in Illinois, taking total announced investment at the site to $33m. The latest investment, following a $15.5m programme announced earlier this year, will fund tw…
Manufacturing
Labiotech
Merck’s new BioReliance® Facility in Darmstadt, Germany, will support biologics testing, GMP release testing and stability studies in Europe. The post Merck’s new BioReliance® Facility in Darmstadt: supporting biologics development and commercialization in Europe appeared first o…
Manufacturing B BioPharm International
Survodutide advances metabolic disease treatment, while biosimilar capacity expands, FDA delays hemophilia review, and lupus data support next steps.
Manufacturing B BioProcess International
The first module is scheduled to open in 2031 with the second to follow in 2034.
Manufacturing P Pharmaceutical Commerce
At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains.
Manufacturing B BioProcess International
The IND pilot is part of the HHS's ongoing mission to onshore clinical trials.
Manufacturing B BioProcess International
Biosimilars and complex biologics introduce analytical challenges that demand assays with high sensitivity, strong reproducibility, and fast turnaround times. As this market analysis shows, high-performance liquid chromatography remains the biopharmaceutical industry’s preferred…
Manufacturing B BioProcess International
Complex biomolecules place unprecedented demands on conventional purification platforms. Although upstream manufacturing has become faster and more productive, downstream purification has struggled to keep pace, creating a bottleneck that directly affects manufacturing efficiency…
Manufacturing
BioPharma Dive
As AI accelerates drug discovery, here are the ways pharmaceutical manufacturing facilities are adapting.
Manufacturing
Pharmaceutical Technology
Bayer has announced plans to invest $2.2bn in a new pharmaceutical manufacturing facility in Ohio, US.
Manufacturing N Nature Reviews Bioengineering
Manufacturing P pharmaphorum
Bayer pledges $2.2bn to US manufacturing facility Phil.Taylor Sun, 04/10/2026 - 18:57
Manufacturing
Fierce Biotech
How to Choose a Biologics CDMO: 4 Criteria That Matter the Most scox Fri, 10/02/2026 - 13:28
Manufacturing P Pharmafile
CeramTec has opened a 12,000m² extension at its Marktredwitz site in Germany, adding around 5,000m² of production space for ceramic components used in hip and knee replacements. The new facility includes cleanroom technology and measurement equipment for the manufacture of medica…
Manufacturing B BioProcess International
An executive for the Boecillo-based CDMO told us how Spain can leverage its strong scientific base to become a manufacturing powerhouse.
Manufacturing
Fierce Pharma
For biopharma manufacturing at speed and scale, the future is flexible scox Thu, 10/01/2026 - 15:28
Manufacturing B BioPharm International
Webinar Date/Time: Fri, Oct 23, 2026 11:00 AM EDT
Manufacturing
Pharmaceutical Technology
Drug delivery’s next bottleneck is manufacturing capacity: scale, validation, and resilient supply chains.